Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM300904
Substrate
n/a
Meas. Tech.
Inositol Phosphate Turnover (IP1) Assay
EC50
27.0±n/a nM
Citation
Chobanian, H; DeMong, D; Plummer, CW; Fang, M; Hu, B [7,6]-fused bicyclic antidiabetic compounds US Patent US10131651 Publication Date 11/20/2018
More Info.:
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
Inhibitor
Name:
BDBM300904
Synonyms:
(2S,3R)-3-((R or S)-2-(1- (2,5-bis(trifluoromethyl)- benzyl)azetidin-3-yl)- 2,3,4,5-tetrahydrobenzo[b]- oxepin-8-yl)-3-cyclopropyl- 2-methylpropanoic acid | US10131651, Example 4
Type:
Small organic molecule
Emp. Form.:
C29H31F6NO3
Mol. Mass.:
555.5518
SMILES:
C[C@@H]([C@@H](C1CC1)c1ccc2CCC[C@@H](Oc2c1)C1CN(Cc2cc(ccc2C(F)(F)F)C(F)(F)F)C1)C(O)=O |r|